Lexaria Bioscience (LEXX) Cost of Revenue (2017 - 2024)
Lexaria Bioscience (LEXX) recorded Cost of Revenue of $2,720 in FY2025 (year ended Aug 31, 2025), down 43.6% from $4,822 in FY2024.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Cost of Revenue (2017 - 2024) Analysis & Trends
Starting with FY2016, Lexaria Bioscience's Cost of Revenue history includes 10 fiscal years.
- Annual Cost of Revenue has declined for four straight fiscal years, with a five-year compound annual growth rate of -51.3% (FY2020 to FY2025).
- The FY2025 figure is the lowest annual Cost of Revenue in data going back to FY2016.
- Per Business Quant data, LEXX's Cost of Revenue was $4,822 in FY2024 (-84.7%), $31,500 in FY2023 (-56.2%), $71,841 in FY2022 (-59.0%) and $175,346 in FY2021 (+76.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2024 | 2,720.00 |
| Nov 30, 2023 | 4,822.00 |
| May 31, 2023 | 12,747.00 |
| Feb 28, 2023 | 2,958.00 |
| Nov 30, 2022 | 15,795.00 |
| Aug 31, 2022 | 41,249.00 |
| May 31, 2022 | 18,635.00 |
| Feb 28, 2022 | 6,387.00 |
| Nov 30, 2021 | 5,570.00 |
| Aug 31, 2021 | 20,309.00 |
| May 31, 2021 | 59,989.00 |
| Feb 28, 2021 | 30,570.00 |
| Nov 30, 2020 | 64,478.00 |
| Aug 31, 2020 | 13,100.00 |
| May 31, 2020 | 20,319.00 |
| Feb 29, 2020 | 58,106.00 |
| Nov 30, 2019 | 7,853.00 |
| Aug 31, 2019 | 14,949.00 |
| May 31, 2019 | 3,096.00 |
| Feb 28, 2019 | 2,690.00 |
API Access
Lexaria Bioscience Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();